Business Description
NeuPath Health Inc
NAICS : 622111
SIC : 8611
ISIN : CA64133P1009
Share Class Description:
TSXV:NPTH: Ordinary SharesTotal Employee Number:
152Compare
Compare
Traded in other countries / regions
NPTH.Canada IPO Date
2020-07-06Description
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions. The company operates in one industry segment: medical services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 3.61 | |||||
Interest Coverage | 3.11 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.22 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year Book Growth Rate | -5.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.78 | |||||
9-Day RSI | 67.9 | |||||
14-Day RSI | 62.76 | |||||
3-1 Month Momentum % | 22.45 | |||||
6-1 Month Momentum % | 15.38 | |||||
12-1 Month Momentum % | 130.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.29 | |||||
Days Sales Outstanding | 36.22 | |||||
Days Payable | 51.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.8 | |||||
Shareholder Yield % | -3.32 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.92 | |||||
Operating Margin % | 2.73 | |||||
Net Margin % | 0.01 | |||||
EBITDA Margin % | 4.06 | |||||
FCF Margin % | 1.58 | |||||
OCF Margin % | 2.71 | |||||
ROE % | 0.04 | |||||
ROA % | 0.02 | |||||
ROIC % | 3.65 | |||||
3-Year ROIIC % | -57.96 | |||||
ROC (Joel Greenblatt) % | 15.53 | |||||
ROCE % | 4.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 92.86 | |||||
Forward PE Ratio | 9.29 | |||||
PE Ratio without NRI | 29.55 | |||||
Price-to-Owner-Earnings | 65 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 1.75 | |||||
Price-to-Free-Cash-Flow | 27.08 | |||||
Price-to-Operating-Cash-Flow | 15.48 | |||||
EV-to-EBIT | 33.41 | |||||
EV-to-EBITDA | 12.81 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-Forward-Revenue | 0.48 | |||||
EV-to-FCF | 32.94 | |||||
Price-to-GF-Value | 2.71 | |||||
Price-to-Projected-FCF | 1.44 | |||||
Earnings Yield (Greenblatt) % | 2.99 | |||||
FCF Yield % | 3.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NeuPath Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 89.368 | ||
| EPS (TTM) (C$) | 0.007 | ||
| Beta | 0.5432 | ||
| 3-Year Sharpe Ratio | 1.19 | ||
| 3-Year Sortino Ratio | 2.98 | ||
| Volatility % | 41.73 | ||
| 14-Day RSI | 62.76 | ||
| 14-Day ATR (C$) | 0.03138 | ||
| 20-Day SMA (C$) | 0.6085 | ||
| 12-1 Month Momentum % | 130.77 | ||
| 52-Week Range (C$) | 0.24 - 0.68 | ||
| Shares Outstanding (Mil) | 56.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeuPath Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NeuPath Health Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
NeuPath Health Inc Frequently Asked Questions
What is NeuPath Health Inc(TSXV:NPTH)'s stock price today?
The current price of TSXV:NPTH is C$0.65. The 52 week high of TSXV:NPTH is C$0.68 and 52 week low is C$0.24.
When is next earnings date of NeuPath Health Inc(TSXV:NPTH)?
The next earnings date of NeuPath Health Inc(TSXV:NPTH) is .
Does NeuPath Health Inc(TSXV:NPTH) pay dividends? If so, how much?
NeuPath Health Inc(TSXV:NPTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on NeuPath Health Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers